Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A randomized Phase II trial of Fulvestrant with or without Ribociclib (LEE011) after progression on aromatase inhibition plus cyclin-dependent kinase 4/6 inhibition in patients with advanced hormone receptor positive, HER2 negative breast cancer |
|---|---|
| Full Title | A randomized Phase II trial of Fulvestrant with or without Ribociclib (LEE011) after progression on aromatase inhibition plus cyclin-dependent kinase 4/6 inhibition in patients with advanced hormone receptor positive, HER2 negative breast cancer |
| Disease/Condition | Medical and Hematologic Oncology |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Sun Young Oh |
| Contact Name | Vilma Calderon |
| Contact Email | aromaner@montefiore.org klora@montefiore.org vcaldero@montefiore.org |
| Protocol Number | IRB# 2016-6975 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | No |
